Navigation Links
Progress Against Malaria: Developments on the Horizon
Date:10/1/2007

October 24, 2007
1 p.m. to 7:30 p.m.
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th Floor
New York, NY 10007

The Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health and The New York Academy of Sciences present Progress Against Malaria: Developments on the Horizon, a half-day symposium to highlight the latest research developments in the fight to combat malaria. This meeting will include discussions of new diagnostic tests, treatment and prevention strategies, and malaria-resistant mosquitoes. The symposium will also feature work from Macha, Zambia, where malaria research is conducted in a unique rural setting.

Online registration is available at www.nyas.org/mraconf. To register by phone or to request accommodations for a disability, call 212-298-8615.

WEDNESDAY, OCTOBER 24, 2007 1:00 PM 5:30 PM

1:00 pm 2:00 pm Registration

2:00 pm 2:15 pm Welcome and Introduction
Ellis Rubinstein, President, The New York Academy of Sciences

2:15 pm 2:45 pm KEYNOTE LECTURE
Current Developments in Malaria Product Innovation and Control
Chris Hentschel, Ph.D., President and Chief Executive Officer, Medicines for Malaria Venture

2:45 pm 3:25 pm SESSION I: The State of the Art and Beyond:
Vaccine Development and Creation of Malaria-Resistant Mosquitoes

Mosquitoes That Cant Get Infected
Marcelo Jacobs-Lorena, Ph.D., Johns Hopkins Malaria Research Institute

Progress and Challenge in the Development of a Malaria Vaccine:
The PATH MVI Perspective
Christian Loucq, M.D., Director, The PATH Malaria Vaccine Initiative

3:25 pm 3:45 pm Coffee Break

3:45 pm 4:45 pm SESSION II: Progress in Diagnosis, Prevention and Treatment
Moderator: Diane Griffin, Ph.D., M.D., Johns Hopkins Bloomberg School of Public Health
'/>"/>

Contact: Tim Parsons
tmparson@jhsph.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. Disease progression model of pancreatic cancer developed by Penn researchers
3. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
4. Progress on HIV/AIDS significant but insufficient
5. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
6. Genome changes tracked during multiple myeloma initiation, progression and treatment
7. Iraqs marshes show progress toward recovery
8. Progress being made in exploring potential use of stem cells to treat heart disease
9. Researchers make progress in studying genetic traits of India-born populations
10. Insulin receptor stops progression of Alzheimers disease
11. Progress made in HIV vaccine development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Research and Markets ... the "iPhone 5S Fingerprint Sensor - Apple/AuthenTec ... to their offering. ... AuthenTec in July 2012, Apple introduced the fingerprint ... currently the only device of Apple incorporating such ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/15/2014)... Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ... "Global Facial Recognition Market 2015-2019" report to ... Facial recognition is a technology ... system measures the overall facial feature of a ... the distance between eyes. Facial recognition is used ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... first got its grip in California,s forests outside a nursery ... before spreading out to eventually kill millions of oaks and ... led by researchers at the University of California, Berkeley. It ... unfolded in this state. "In this paper, we actually ...
... researchers have discovered an important clue to how iron ... the body. The finding could lead to developing new ... nutritional disorder., With C. elegans, a common microscopic worm ... animal and avian sciences, and his team identified previously ...
... have developed a technique for imaging cells under an electron ... chromatin, the tightly wound bundle of genetic material and proteins ... Nature Methods. Scientists have known for more than a ... into the nucleus of a cell. Human cells contain 2 ...
Cached Biology News:Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic 2Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic 3Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic 4Bloodless worm sheds light on human blood, iron deficiency 2Bloodless worm sheds light on human blood, iron deficiency 3New technique yields more detailed picture of chromatin structure 2New technique yields more detailed picture of chromatin structure 3
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
(Date:12/22/2014)... Dec. 22, 2014 GenomeDx Biosciences today announced ... Cancer Classifier, a genomic test for prostate cancer, was ... men managed by radical prostatectomy without adjuvant therapy. Although ... relatively uncommon, using tumor genomics to identify these men ... is an important advance. The study has been ...
(Date:12/19/2014)... Hershey, PA (PRWEB) December 19, 2014 ... a leading developer and manufacturer of needle-free injection ... an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ... injection device with its LAMP™ vaccine platform. ... for an exclusive Worldwide license to the Biojector®-2000 ...
(Date:12/19/2014)... -- Bina Technologies, Inc. (Bina, Redwood City, ... been acquired by Roche (SIX: RO, ROG; OTCQX: RHHBY).  ... that provides a big data platform for centralized management ... the academic and translational research markets.  Bina will be ... to focus on development of their innovative genomic analysis ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
... Magnetics, the first start-up company spun off by The ... advance development of an innovative drug delivery system using ... Vascular Magnetics, based in West Philadelphia, announced that ... investor in this Series A financing agreement. ...
... March 1, 2012 Reportlinker.com announces that ... in its catalogue: Global ... The global outlook series on Biotechnology ... briefs, and concise summaries of research findings. ...
... that the company is scheduled to present at the Cowen ... on Wednesday, March 7, 2012, at the Boston Marriott Copley ... officer, will provide an overview of the company and an ... is an exciting time at Receptos as we move forward ...
Cached Biology Technology:Biotech Firm Spun Off from Children's Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment 2Biotech Firm Spun Off from Children's Hospital Raises $7 Million to Advance Magnetic-Based Vascular Treatment 3Global Biotechnology Industry 2Global Biotechnology Industry 3Global Biotechnology Industry 4Global Biotechnology Industry 5Global Biotechnology Industry 6Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference 2
... low background ,This solution greatly enhances antigen-antibody ... than obtained with conventional methods. ,Two kinds ... secondary antibodies, which can suppress the background ... Wide versatility ,It is applicable to various ...
Monocarboxylate (lactate) transporter 2...
Mouse anti human pro-Relaxin-2...
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Biology Products: